# Tokyo Metropolitan Police Hospital

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/tokyo-metropolitan-police-hospital/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 63 |
| Citations | 45,522 |
| City | Tokyo |
| Country | JP |
| Description | Tokyo Metropolitan Police Hospital is a research organisation in Tokyo, JP. OpenAlex records 1,071 works and 45,522 citations for it. 290 researchers list it as their most recent affiliation. |
| Homepage | http://www.keisatsubyoin.or.jp/ |
| OpenAlex ID | https://openalex.org/I4210159339 |
| Researchers | 290 |
| ROR ID | https://ror.org/05nyma565 |
| Type | healthcare |
| Works | 1,071 |

## University papers

- [Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial](https://scholariq.org/papers/pembrolizumab-in-patients-with-advanced-hepatocellular-carcinoma-previously/)
- [A Liver-Derived Secretory Protein, Selenoprotein P, Causes Insulin Resistance](https://scholariq.org/papers/a-liver-derived-secretory-protein-selenoprotein-p-causes-insulin-resistance/)
- [Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial](https://scholariq.org/papers/combination-gemcitabine-plus-s-1-versus-gemcitabine-plus-cisplatin-for-advanced/)
- [Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial](https://scholariq.org/papers/lenvatinib-versus-sorafenib-for-first-line-treatment-of-unresectable/)

## University top topics

Showing 8 of 25.

- [Reconstructive Surgery and Microvascular Techniques](https://scholariq.org/topics/reconstructive-surgery-and-microvascular-techniques/)
- [Reconstructive Facial Surgery Techniques](https://scholariq.org/topics/reconstructive-facial-surgery-techniques/)
- [Gallbladder and Bile Duct Disorders](https://scholariq.org/topics/gallbladder-and-bile-duct-disorders/)
- [Facial Nerve Paralysis Treatment and Research](https://scholariq.org/topics/facial-nerve-paralysis-treatment-and-research/)
- [Meningioma and schwannoma management](https://scholariq.org/topics/meningioma-and-schwannoma-management/)
- [Intracranial Aneurysms: Treatment and Complications](https://scholariq.org/topics/intracranial-aneurysms-treatment-and-complications/)
- [Craniofacial Disorders and Treatments](https://scholariq.org/topics/craniofacial-disorders-and-treatments/)
- [Cleft Lip and Palate Research](https://scholariq.org/topics/cleft-lip-and-palate-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.